공고 • Apr 16
Moolec Science SA, Annual General Meeting, May 13, 2026 Moolec Science SA, Annual General Meeting, May 13, 2026. 공고 • Feb 27
Moolec Science SA Announces Board and Committee Changes, Effective February 25, 2025 Moolec Science SA announced changes to the composition of its Board of Directors. Daniel Core has been appointed to the Company's Board of Directors, effective February 25, 2025. Mr. Core has also been appointed as a member of the Audit Committee and the Compensation Committee of the Board. Daniel Core is a U.S.-based quality and operations professional with more than three decades of experience in industrial manufacturing environments. His background includes quality leadership roles across multinational and precision manufacturing organizations, with a focus on operational discipline, compliance, and process integrity. Mr. Core has held quality assurance and quality leadership positions with organizations including Illinois Tool Works, MW Components, Aptix, and Stanley Black & Decker. His experience spans the implementation and oversight of established quality management systems and regulatory frameworks commonly applied in regulated manufacturing sectors. He has extensive experience supporting internal and external audit processes, strengthening quality systems, and contributing to continuous improvement initiatives focused on risk reduction, cost discipline, and operational efficiency. Mr. Core currently serves in a quality leadership role within the manufacturing sector in New England. He brings a disciplined, systems-oriented perspective to Board discussions, informed by hands-on experience with quality governance, compliance environments, and operational risk management. Aimar Dimo and Gloria Montaron Estrada have each resigned from the Company's Board of Directors, effective February 25, 2025. 공고 • Nov 23
Moolec Receives Nasdaq Determination Letter Moolec Science SA announced that it received a determination letter (the "Nasdaq Determination Letter") from the Nasdaq Stock Market LLC ("Nasdaq") indicating that the closingbid price of the Company's ordinary shares had been below the minimum $1.00 per share requirement for the last 30 consecutive business days, as set in Nasdaq Listing Rule 5550(a)(2), and informing the Company of their view that the Company would not be afforded an automatic 180-day period to regain compliance with such rule. The Company has submitted a timely appeal to a Nasdaq Hearings Panel, through which it will request the granting of a 180- day period to submit and effect a compliance plan, which will include a potential implementation of a reverse stock split, if determined to be in the best interest of shareholders. The submission of the appeal automatically stays the effect of the Nasdaq Determination Letter until the appeal has been considered, which will take place on December 18, 2025. Accordingly, the Company's ordinary shares will continue to trade on The Nasdaq Capital Market under the symbol "MLEC" without interruption during such stay. The Company intends to continue closely monitoring the closingbid price for its ordinary shares and remains committed to evaluating and executing all appropriate actions to cure the deficiency and regain compliance with Nasdaq Listing Rule 5550(a)(2). The receipt of the Nasdaq Determination Letter does not affect the Company's business, operations or reporting requirements with the Securities and Exchange Commission. 공고 • Nov 04
Moolec Science SA announced delayed 20-F filing On 11/03/2025, Moolec Science SA announced that they will be unable to file their next 20-F by the deadline required by the SEC. 공고 • Sep 12
Moolec Science SA Appoints Valeria Falottico as New Chief Financial Officer Moolec Science SA announced the appointment of a new Chief Financial Officer to strengthen its leadership team. Moolec has appointed Valeria Falottico as its new Chief Financial Officer, providing continuity after CEO Alejandro Antalich temporarily assumed the role on an interim basis during the Company's restructuring. Ms. Falottico brings more than 20 years of experience in consulting, financial services, and capital markets across the U.S., Asia and Latin America. She has held senior leadership roles in multinational organizations, driving capital raising, IPOs, M&A, and other strategic transactions. She joined Moolec in 2023 and has since held several key leadership roles in financial and compliance reporting. Prior to Moolec, she served in senior positions at NASDAQ trading public company dLocal and PayClip, and earlier spent 17 years at PricewaterhouseCoopers in Argentina and Mexico, advising clients worldwide. She holds an Accounting degree and an MBA from IAE Business School. New Risk • Aug 15
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: US$9.81m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Market cap is less than US$10m (US$9.81m market cap). Minor Risk Share price has been volatile over the past 3 months (12% average weekly change). 
